Blis Technologies reported revenue for the first quarter ending June 30 was up $2.8 million to $3.4m, from $600,000 year on year. The NZX-listed probiotic manufacturer based in Dunedin also recorded an ebitda of $500,000 for the period. Business-to-business revenue for the first quarter of FY25 was
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).